Guangxi LiuYao Group News

Liuyao Group (603368): Optimizing the Wholesale Business Variety Structure and Omni-Channel Layout of Industrial Business

Caitong.Mar 27 15:28

Liu Pharmaceutical Group (603368): Steady 24-year performance, significant improvement in cash flow

HTSCMar 26 00:00

Liu Pharmaceutical Group (603368): Tripartite Cooperation to Promote “AI+ Healthcare” Full-Scenario Application Solution Implemented in & Outside Hospitals or New Applications

Cinda SecuritiesMar 13 18:07

Liu Pharmaceutical Group (603368): The three major businesses are gradually improving and accelerating expansion outside the province

caitong securitiesOct 30, 2024 19:32

Liu Pharmaceutical Group (603368): Distribution business growth is slowing down, waiting for the industry to improve

Aug 29, 2024 19:16

Liu Pharmaceutical Group (603368): Firmly fulfilling expectations, full-year results are expected to accelerate quarter by quarter

May 6, 2024 00:00

SDIC Securities released a research report on April 28 stating that it gave Liuyao Group (603368.SH) a purchase rating, and the target price was 28.32 yuan. The main reasons for the rating include: 1) Incident: The company released its 2023 annual report

Zhitong FinanceApr 28, 2024 18:20

Liuyao Group (603368): Steady growth in wholesale business and accelerated retail and industrial layout are expected to open up room for growth

Apr 28, 2024 00:00

Liu Pharmaceutical Group (603368): High growth in the industrial sector and continuous improvement in profits in 23 years

Apr 26, 2024 13:26

Liuyao Group (603368): High net profit growth in 4Q23 is in line with equity incentive targets

Mar 20, 2024 09:21

Liu Pharmaceutical Group (603368): Guangxi Pharmaceutical Wholesale Leader Diversified Development of Retail Industry Shapes Second Growth Curve

Feb 28, 2024 07:46

Liu Pharmaceutical Group (603368): Leading regional pharmaceutical distribution, pharmaceutical industry leading cross-regional development

Feb 25, 2024 00:00

Analysis of the investment value of Liu Yao's debt conversion: the industrial sector is rapidly developing, and both original stock and debt conversion valuations are low

Jan 2, 2024 18:32

Review of the 2023 Third Quarter Report of Liuyao Group (603368): Steady growth in performance and significant improvement in cash flow

Industrial SecuritiesOct 30, 2023 14:17

Liuyao Group (603368): Wholesale business maintains steady and rapid industrial business development

CaitongOct 26, 2023 00:00

Liu Pharmaceutical Group (603368): 3Q profit grew steadily and industrial business continued to expand

HTSCOct 25, 2023 00:00

Liu Yao Group (603368): Wholesale-side customer stickiness increases, industrial-side marketing results are shown

興業證券Aug 30, 2023 13:52

Liu Pharmaceutical Group (603368): Optimizing the Pharmaceutical Distribution Structure and Rapid Growth of the Pharmaceutical Industry

財通證券Aug 29, 2023 00:00

Liu Pharmaceutical Group (603368): Outstanding industrial business performance in 2Q23

華泰證券Aug 28, 2023 00:00

Liuyao Group (603368) In-depth Report: Steady and comprehensive business coverage, leading advantages accelerate development

東北證券Aug 14, 2023 00:00